Highlights of Ending Age-Related Diseases 2020
Key points from 20 presentations from world-leading researchers
Judith Campisi
Professor of biogerontology and Biochemist.
Judith
Campisi is an American biochemist and cell biologist. She is a
professor of biogerontology at the Buck Institute for Research on Aging.
She is also a member of the SENS Research Foundation Advisory Board and
an adviser at the Lifeboat Foundation.
She is Founder of Academy for Health & Lifespan Research.
Judith Campisi died January 2024.
Visit website: https://en.wikipedia.org/wiki/Judith_Campisi
See also: 
Buck Institute
- Independent biomedical research institute focused on aging
Details last updated 22-Oct-2019
Mentioned in this Resource
Academy for Health and Lifespan Research (AHLR)
World's aging researchers unite to accelerate breakthroughs in longevity
Judith Campisi is also referenced in the following:
Academy for Health and Lifespan Research (AHLR)
World's aging researchers unite to accelerate breakthroughs in longevity
ARDD 2022 - 9th Aging Research and Drug Discovery Meeting
29-Aug-2022 to 02-Sep-2022
Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen
Campisi lab
Campisi lab studies the regulation and characteristics of cell states, with an emphasis on cellular senescence
Healthy Ageing (Virtual Conference)
25-May-2022 to 27-May-2022
Virtual conference by Wellcome Connecting Science with Judith Campisi as a keynote speaker
Judith Campisi Blog Posts
10-Sep-2020
Judith Campisi News
A new method called FAST studies cellular ageing in cultured cells
Live Forever Club - 18-Jan-2024
FAST is precise and works with different cell types and microscopes
Read more...First ever non-invasive biomarker test to detect senolysis
Buck Institute - 02-Apr-2021
Detectible senescence-specific biomarker allows development of new drugs for age-related conditions
Read more...Review on the relationship between senescence and bone marrow cancer
Lifespan.io (LEAF) - 23-Mar-2020
How senescence can fuel cancer development and how malignant cells induce senescence
Read more...Comprehensive history and explanation of senescent cells
The Scientist - 01-Mar-2020
Including the latest on clinical trials of first-generation senolytics
Read more...SASP Atlas created by team of researchers
Lifespan.io (LEAF) - 28-Jan-2020
It is a comprehensive proteomic database of soluble proteins and exosomal cargo SASP factors
Read more...Senescent cells amplify blood clotting - now protein targets identified
Buck Institute - 24-Sep-2019
Could help tackle venous thrombosis that becomes a bigger risk with age
Read more...Dr. Campisi talks about improvements in senolytics and ageing research
Lifespan.io (LEAF) - 03-Apr-2019
Unlike cancer, you don't have to kill every senescent cell
Read more...Senolytics for IPF human clinical trial results released
Lifespan.io (LEAF) - 07-Jan-2019
Physical improvements recorded, but pulmonary function was unchcanged
Read more...The path to an extended health span and a healthier death
MIT Technology Review - 23-Oct-2018
Still a long way to go before expanding life span
Read more...To stay young, kill zombie cells
Nature - 24-Oct-2017
Proof-of-concept trials starting that pit senolytic drugs against a range of age-related ailments...
Read more...Clearing the Body’s Retired Cells Slows Aging and Extends Life
The Atlantic - 03-Feb-2016
Cells accumulate damage in their DNA. Eventually become senescent – i.e. they stop dividing – an...
Read more...Secret to old age health could lie in purging worn-out cells
New Scientist - 16-Sep-2015
Cells eventually stop dividing to replace damaged neighbours and to into senescence. Senescent c...
Read more...
